Molecular cytogenetic characterization of an ins(4;X) occurring as the sole abnormality in an aggressive, poorly differentiated soft tissue sarcoma

Virchows Archiv

Volumn 447, Issue 5, 2005, Pages 869-874

  Surace, Cecilia ^a,b   Storlazzi, Clelia Tiziana ^b   Engellau, Jacob ^a   Domanski, Henryk A ^a   Gustafson, Pelle ^a   Panagopoulos, Ioannis ^a   D'Addabbo, Pietro ^b   Rocchi, Mariano ^b   Mandahl, Nils ^a   Mertens, Fredrik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Cancer; Cytogenetics; In situ hybridization; Sarcomas

Indexed keywords

BUSULFAN; CISPLATIN; CONTIG; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; PROTEIN; PROTEIN BCOR; SCLEROPROTEIN; TROFOSFAMIDE; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; APOPTOSIS; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CASE REPORT; CELL MIGRATION; CHROMOSOME 4; CHROMOSOME ABERRATION; CHROMOSOME DELETION; COMPARATIVE STUDY; CYTOGENETICS; DISEASE COURSE; EMBRYO DEVELOPMENT; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MALE; MESENCHYME CELL; MOLECULAR CLONING; MOLECULAR GENETICS; NEUROECTODERM TUMOR; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SEA URCHIN; SOFT TISSUE SARCOMA; TELOMERE; X CHROMOSOME;

ADOLESCENT; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 4; CHROMOSOMES, HUMAN, X; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; HUMANS; IN SITU HYBRIDIZATION; MALE; NEUROECTODERMAL TUMORS, PRIMITIVE; SARCOMA; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 28444449823     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-0041-0     Document Type: Article

References (13)

1. Burg MA, Nishiyama A, Stallcup WB (1997) A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. Exp Cell Res 235:254-264
2. Burg MA, Grako KA, Stallcup WB (1998) Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells. J Cell Physiol 177:299-312
3. Burg MA, Pasqualini R, Arap W, Ruoslahti E, Stallcup WB (1999) NG2 proteoglycan-binding peptides target tumor neovasculature. Cancer Res 59:2869-2874
4. Hodor PG, Illies MR, Broadley S, Ettensohn CA (2000) Cell-substrate interactions during sea urchin gastrulation: migrating primary mesenchyme cells interact with and align extracellular matrix fibers that contain ECM3, a molecule with NG2-like and multiple calcium-binding domains. Dev Biol 222:181-194
5. Höglund M, Johansson B, Pedersen-Bjergaard J, Marynen P, Mitelman F (1996) Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2. Blood 87:324-330
6. Huynh KD, Fischle W, Verdin E, Bardwell VJ (2000) BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev 14:1810-18233
7. ISCN (1995) An international system for human cytogenetic nomenclature. Mitelman F (ed). Karger, Basel
8. Mandahl N, Heim S, Arheden K, Rydholm A, Willen H, Mitelman F (1988) Three major cytogenetic subgroups can be identified among chromosomally abnormal solitary lipomas. Hum Genet 79:203-208
9. McGregor L, Makela V, Darling SM, Vrontou S, Chalepakis G, Roberts C, Smart N, Rutland P, Prescott N, Hopkins J, Bentley E, Shaw A, Roberts E, Mueller R, Jadeja S, Philip N, Nelson J, Francannet C, Perez-Aytes A, Megarbane A, Kerr B, Wainwright B, Woolf AS, Winter RM, Scambler PJ (2003) Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein. Nat Genet 34:203-208
10. Mitelman F, Johansson B, Mertens F (eds) (2001) Mitelman database of chromosome aberrations in cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman
11. Ng D, Thakker N, Corcoran CM, Donnai D, Perveen R, Schneider A, Hadley DW, Tifft C, Zhang L, Wilkie AO, van der Smagt JJ, Gorlin RJ, Burgess SM, Bardwell VJ, Black GC, Biesecker LG (2004) Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR. Nat Genet 36:411-416
12. Panagopoulos I, Mertens F, Isaksson M, Limon J, Gustafson P, Skytting B, Akerman M, Sciot R, Dal Cin P, Samson I, Iliszko M, Ryoe J, Debiec-Rychter M, Szadowska A, Brosjo O, Larsson O, Rydholm A, Mandahl N (2001) Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer 31:362-372
13. Srinivasan RS, de Erkenez AC, Hemenway CS (2003) The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor. Oncogene 22:3395-3406